IP Alert: Does Secret Prior Art Survive in the AIA? Twelve Interested Parties Weigh In
NEWS -Does Secret Prior Art Survive in the AIA? Twelve Interested Parties Weigh In By Sarah A. Kagan In May, a panel of the U.S. Court of Appeals for the
Does Secret Prior Art Survive in the AIA? Twelve Interested Parties Weigh In By Sarah A. Kagan In May, a panel of the U.S. Court of Appeals for the
Company Founder Joined and Potentially Liable for Attorneys’ Fees — An Interesting Wrinkle in a Typical “Exceptional” Case By Scott M. Kelly and Apurv Gaurav In the wake of
Full Panel of Fed. Cir. Clarifies that Even Voluntarily Dismissed Cases Start the Year Time-Bar Clock for Inter Partes Review By Bradley J. Van Pelt and Kevin C. Keenan
Joseph J. Berghammer, Timothy C. Meece, Jon O. Nelson, Binal J. Patel, Joseph M. Potenza, Christopher J. Renk, Charles W. Shifley and Bradley C. Wright are listed as leaders in intellectual property
Standing to Appeal Comes into Focus By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit took another step toward defining the contours of standing to
Scott M. Kelly, assistant editor of Banner & Witcoff’s PatentArcade.com, discusses how Dream Arcades emulation console, Dreamcade Replay, could potentially face issues with copyright infringement in GameDaily.biz. Click here to read the article, “The Dreamcade Replay all-in-one
On May 22, 2018, Banner & Witcoff secured a jury verdict for client, Buc-ee’s, against a chain of travel centers in Texas. The 12-person jury returned a unanimous verdict that Buc-ee’s
Banner & Witcoff, Ltd., a national intellectual property law firm that procures, enforces and litigates intellectual property rights throughout the world, welcomed five new associates in the first half of
Christopher L. McKee examines 21 inter partes review decisions made after the Supreme Court’s ruling in SAS Inst., Inc. v. Iancu to determine whether the filing of a preliminary response by
Obviousness-By-Inherency Argument Nixed By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit affirmed on July 13 a Delaware district court’s decision that patent challenger Custopharm